PRIA Pages Newsletter H1 2026 - Q1 & Q2 Highlights

PRIA Healthcare • September 10, 2026

The latest issue of PRIA Pages covers all of our many activities throughout the first and second quarters of 2026, combined into one comprehensive summary!   


LSI USA 2026, The MedTech Strategist Innovation Summit in Dublin, and Medtech Innovator's Radar Forum were just some of the exciting MedTech industry events that PRIA participated in over the past many months.


PRIA added Regulatory & Quality services to our client offerings, welcoming Sam Murray to lead that new department.  We also welcomed new go-to-market expert Suzy Engwall to the team!


In our commitment to staying abreast of industry news and sharing our expertise with our clients and followers, we hosted two successful webinars. One was produced in conjunction with MDMA, featuring PRIA's clients sharing their experiences with Patient Access.  Another included special guest Dr. Brian Solow, former Chief Medical Officer of Optum Life Sciences, along with PRIA’s Tonya Dowd, Sam Murray and Suzy Engwall, in a discussion on what innovators should know about Breakthrough designation when building an their regulatory and reimbursement strategy.


We expanded our range of informative articles, with new series on reimbursement, regulatory, and commercialization topics.


It has been a busy and exciting year so far!  Stay tuned for what the rest of the year brings!


Click to Open the PDF

PRIA Pages H1 2026

Click the Icon below to share this with your network

The first in a series on the shifting landscape of patient access
By Chelsy Peet August 20, 2026
The first in a series on the shifting landscape of patient access, from inside the team that fights for the patient's first stamp on their passport.
RAPID and the Long Effort to Close Medicare's Coverage Gap by Tonya Dowd and Sam Murray
By Tonya Dowd & Sam Murray August 17, 2026
FDA authorization does not guarantee timely Medicare coverage. RAPID is CMS’s latest attempt to narrow that gap—and potentially one of its most consequential.
PRIA's webinar, How Payers Decide: Coverage, Evidence, and Value in MedTech Commercialization
July 28, 2026
PRIAs webinar, How Payers Decide: Coverage, Evidence, and Value in MedTech Commercialization featuring Dr. Julie Kessel and Dr. Dot Verbrugge
Stop Guessing What FDA Wants by Sam Murray
By Sam Murray June 4, 2026
Stop Guessing What FDA Wants
Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough & Beyond
June 3, 2026
Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough and Beyond
You Got Your 510(k). Now What?
By Suzy Engwall May 28, 2026
You Got Your 510(k). Now What?
Right Sizing Your Quality System by Sam Murray
By Sam Murray, Head of Regulatory & Quality May 21, 2026
Right Sizing Your Quality System
Cleared for takeoff: Insights from a Medtech First Officer
By Suzy Engwall May 19, 2026
Five Mistakes MedTech StartUps Make Before Their First VAC Meeting
Using Regulatory as a Strategy and Not a Milestone
By Sam Murray, PRIA May 14, 2026
Using Regulatory as a Strategy and Not a Milestone
Reading the Water: Navigating What Matters in Regulatory and Quality  - Sam Murray, PRIA
By Sam Murray, Head of Regulatory & Quality May 6, 2026
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
Medical device strategy CMS/FDA RAPID program
By Tonya Dowd & Sam Murray April 24, 2026
Examining the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier.
MedTech Clinical Evidence Strategy
By PRIA Healthcare April 20, 2026
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.